Skip to main content
Fig. 1 | Parasites & Vectors

Fig. 1

From: Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease

Fig. 1

Results of the level of antibodies (median ± interquartile range) against Leishmania infantum at the time of diagnosis (day 0) and during the anti-Leishmania treatment* (days 30, 180 and 365) in 37 dogs with clinical leishmaniosis (at least stage II, moderate disease) **. *Anti-Leishmania treatment: meglumine antimoniate (100 mg/kg/SID/SC/30 days) combined with allopurinol (10 mg/kg/BID/PO/1 year). **Comparison between day 0 with the other days [day 30 (Wilcoxon signed-rank test: Z = -4.839, P < 0.0001), day 180 (Z = -4.895, P < 0.0001) and day 365 (Z = -4.703, P < 0.0001)]. Comparison between day 30 and day 180 (Z = -3.865, P < 0.0001), day 30 - day 365 (Z = -4.623, P < 0.0001) and day 180 - day 365 (Z = -4.335, P < 0.0001)

Back to article page